https://www.selleckchem.com/pr....oducts/phycocyanobil
042). The 2-year and 5-year OS for patients receiving primary tumor resection and EGFR-TKIs was 90.0% and 60.1%. Primary tumor resection was associated with improved survival in patients with occult intraoperatively-confirmed M1a adenocarcinoma receiving EGFR-TKIs. Primary tumor resection was associated with improved survival in patients with occult intraoperatively-confirmed M1a adenocarcinoma receiving EGFR-TKIs.Among cancers that affect the central nervous system, glioblastoma is the most common. Given the negative prognostic
Like
Comment
Share
